X
Please Wait
Applying Filters...
01 OTSUKA (4)
01 TABLET, ORALLY DISINTEGRATING;ORAL (4)
01 DISCN (4)
01 ABILIFY (4)
01 Yes (4)
19
Otsuka Chemical Co Ltd, based in Japan, is a pharmaceutical company.
One of their notable products is ARIPIPRAZOLE, with a corresponding application number 21729.
Regulatory Information DISCN
With a dosage strength 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2006-06-07
18
Otsuka Chemical Co Ltd, based in Japan, is a pharmaceutical company.
One of their notable products is ARIPIPRAZOLE, with a corresponding application number 21729.
Regulatory Information DISCN
With a dosage strength 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2006-06-07
17
Otsuka Chemical Co Ltd, based in Japan, is a pharmaceutical company.
One of their notable products is ARIPIPRAZOLE, with a corresponding application number 21729.
Regulatory Information DISCN
With a dosage strength 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2006-06-07
16
Otsuka Chemical Co Ltd, based in Japan, is a pharmaceutical company.
One of their notable products is ARIPIPRAZOLE, with a corresponding application number 21729.
Regulatory Information DISCN
With a dosage strength 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL
Reference Listed Drug Yes
Approved since 2006-06-07
Market Place
